Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria

Gabriela Marinho Righetto1, José Luiz de Souza Lopes2, Paulo José Martins Bispo3

  • 1Laboratory of Molecular Epidemiology and Microbiology, Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo, São Carlos 13563-120, Brazil.

Insights

A novel antimicrobial peptide, Pln149-PEP20, shows potent bactericidal activity against multidrug-resistant bacteria. This peptide likely targets bacterial membranes, offering a promising new therapeutic avenue for combating antimicrobial resistance.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Antimicrobial resistance (AMR) is a significant global health threat.
  • Novel antimicrobial agents are urgently needed to combat multidrug-resistant (MDR) bacteria.
  • Antimicrobial peptides (AMPs) are being investigated as potential therapeutics against resistant infections.

Purpose of the Study:

  • To design and characterize a novel analog of the antimicrobial peptide Plantaricin 149 (Pln149-PEP20).
  • To evaluate the antimicrobial activity and resistance development potential of Pln149-PEP20.
  • To elucidate the mechanism of action of Pln149-PEP20 against bacteria.

Main Methods:

  • Minimal inhibitory concentrations (MICs) determination for 60 bacterial strains.
  • In vitro directed-evolution experiment to assess resistance development.
  • Whole-genome sequencing of resistant mutants.
  • Synchrotron radiation circular dichroism, membrane depolarization, and transmission electron microscopy (TEM) assays.

Main Results:

  • Pln149-PEP20 exhibited potent bactericidal activity against Gram-positive and Gram-negative bacteria, with MICs ranging from 1 to 512 mg/L.
  • Most mutations in resistant mutants were found in genes related to membrane metabolism.
  • Pln149-PEP20 was shown to disturb bacterial membranes, suggesting a carpet-like mechanism of action.

Conclusions:

  • Pln149-PEP20 demonstrates significant potential as a novel antimicrobial therapeutic.
  • The peptide's primary mechanism involves disruption of bacterial membranes.
  • Further optimization of Pln149-PEP20 may lead to effective treatments for resistant bacterial infections.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
2.0K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
107
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
59